H. Noda

Effects of calcium channel blocker-based combinations on intra-individual blood pressure variability: post hoc analysis of the COPE trial

T. Ogihara, W. Kajiyama, K. Kario, 2015, Hypertension Research.

Effects of calcium channel blocker benidipine-based combination therapy on target blood pressure control and cardiovascular outcome: a sub-analysis of the COPE trial

T. Ogihara, W. Kajiyama, K. Kario, 2016, Hypertension Research.

GIP Receptor Antagonist, SKL-14959 Indicated Alteration of the Lipids Metabolism to Catabolism by the Inhibition of Plasma LPL Activity, Resulting in the Suppression of Weight Gain on Diets-Induced Obesity Mice

H. Noda, Y. Tsubamoto, Takashi Nakamura, 2021, Diabetes, metabolic syndrome and obesity : targets and therapy.

Gastric inhibitory polypeptide receptor antagonist, SKL‐14959, suppressed body weight gain on diet‐induced obesity mice

H. Noda, Y. Tsubamoto, Y. Mizuno, 2018, Obesity science & practice.

Biological and functional characteristics of a novel low–molecular weight antagonist of glucose‐dependent insulinotropic polypeptide receptor, SKL‐14959, in vitro and in vivo

H. Noda, Y. Tsubamoto, Y. Mizuno, 2012, Diabetes, obesity & metabolism.